Isolation of Causative Microorganism and Antimicrobial Susceptibility in Impetigo

Korean Journal of Dermatology

Volumn 41, Issue 10, 2003, Pages 1278-1285

  Bae, Eun Young ^a   Lee, Jeong Deuk ^a   Cho, Sang Hyun ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Antimicrobial susceptibility; Impetigo; MRSA; Staphylococcus aureus

Indexed keywords

CEFALOTIN; CEFAZOLIN; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; METICILLIN; NITROFURANTOIN; NOVOBIOCIN; OXACILLIN; PENICILLIN G; PIPERACILLIN; PSEUDOMONIC ACID; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CITROBACTER; CITROBACTER BRAAKII; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG RESPONSE; HUMAN; IMPETIGO; KLEBSIELLA; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; OXACILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS GROUP A;

EID: 0242662499     PISSN: 04944739     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Hogan P. Pediatric dermatology. Impetigo. Aust Fam Physician 1998;27:735-736
2. Dagon R. Impetigo in childhood: Changing epidemiology and new treatments. Pediatr Ann 1993;22:235-240
3. Stulberg DL, Penrod MA, Blatny RA. Common bacterial skin infections. Am Fam Physician 2002;66:119-124
4. Esterly NB, Markowitz M. The treatment of pyoderma in children. JAMA 1970;212:1667-1670
5. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility tests, 6th ed. 1997
6. Van Toorn MJ. On the staphylococcal and streptococcal etiology of impetigo. Dermatologica 1961;123:391-399
7. Dajani AS, Ferrieri P, Wannamaker LW. Natural history of impetigo. II. Etiologic agents and bacterial interactions. J Clin Invest 1972;51:2863-2871
8. Dillon HC, Moody MD, Maxted WR, Parker MT. The epidemiology of impetigo and acute glomerulonephritis. Results of serological typing of group A Streptococci. Am J Epidem 1967;86:710-723
9. Dillon HC. Impetigo contagiosa: suppurative and non-suppurative complications. I. Clinical, bacteriologic, and epidemiologic characteristics of impetigo. Am J Dis Child 1968;115:530-541
10. Noble WC. Skin bacteriology and the role of Staphylococcus aureus in infection. Br J Dermatol 1998;139: 9-12
11. Ruby RJ, Nelson JD. The influence of hexachlorophene scrubs on the response to placebo or penicillin therapy in impetigo. Pediatrics 1973;52:854-859
12. Dillon HC. The treatment of streptococcal skin infections. J Pediatr 1970;76:676-684
13. Hughes WT, Wan RT. Impetigo contagiosa: etiology, complications, and comparison of therapeutic effectiveness of erythromycin and antibiotic ointment. Am J Dis Child 1967;113:449-453
14. Nishijima S, Nakagawa M. Sensitivity of antibacterials of Staphylococcus aureus isolated from impetigo patients. J Int Med Res 1997;25:210-213
15. Klein PA. Prevalence of Methicillin-resistant Staphylococcus aureus in outpatients with psoriasis, atopic dermatitis, or HIV infection. Arch Dermatol 1997;133:1463-1464
16. Murakami K, Nomura K, Doi M, Yoshida T. Production of low affinity penicillin-binding protein by low and high resistance proups of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1987;31: 1307-1311
17. Nishijima S, Namura S, Nakagawa M, Kurokawa I, Kawabata S. Sensitivity to antibacterials of Staphylococcus aureus isolated from different types of skin infections. J Int Med Res 1997;25:1-7
18. Couppie P, Sainte-Marie D, Prevost G, Gravet A, Clyti E, Moreau B, et al. Impetigo in French Guyana. A clinical, bacteriological, toxicological and sensitivity to antibiotics study. Ann Dermatol Venereol 1998;125:688-693
19. Neu HC. Antistaphylococcal Penicillins. Med Clin North Am 1982;66:51-60
20. Light JH. Penicillinase-Resistant Penicillin/Gentamycin Synergism. Effect in patients with Staphylococcus aureus bacteremia. Arch Intern Med 1979;139:1094-1098
21. Dagan R, Bar-David Y. Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: Implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 1992;36:287-292
22. Barton LL, Freidman AD, Sharkey AM, Schneller DJ, Swierkosz EM. Impetigo contagiosa III. Comparative efficacy of oral erythromycin, and topical mupirocin. Pediatr Dermatol 1989;6:134-138
23. Goldfarb J, Crenshaw D, O'Horo J, Lemon E, Blumer JL. Randomized clinical trial of topical mupirocin versus oral erythromycin for impetigo. Antimicrob Agents Chemother 1988;32:1780-1783
24. McKinn S. Topical mupirocin versus systemic erythromycin treatment for pyoderma. Pediatr Infect Dis J 1988;7:785-790